All currency values in $ millions unless otherwise noted
Scroll
| Income Statement | TTM | JAN 2026 | JAN 2025 | JAN 2024 | JAN 2023 | JAN 2022 |
|---|---|---|---|---|---|---|
| Revenues | ||||||
| Revenue | $508 | $481 | $420 | $356 | $281 | $213 |
| Cost of Revenue | $300 | $286 | $284 | $301 | $286 | $209 |
| Gross Profit | $208 | $195 | $136 | $56 | -$5 | $4 |
| Operating Expenses | ||||||
| Selling & Marketing | $98 | $100 | $121 | $147 | $151 | $106 |
| General & Administrative | $79 | $80 | $77 | $80 | $80 | $69 |
| Research & Development | $116 | $121 | $117 | $112 | $91 | $52 |
| Provision for Doubtful Accounts | -$0 | $1 | $1 | $0 | $1 | $0 |
| Total Operating Expenses | $495 | $487 | $478 | $493 | $457 | $330 |
| Operating Income | $13 | -$7 | -$58 | -$136 | -$177 | -$117 |
| Non-Operating | ||||||
| Net Interest Expense | -$9 | -$5 | $0 | $2 | $1 | -$1 |
| Other Non-Operating Income (Expense) | -$1 | $2 | $2 | -$1 | -$0 | $0 |
| EBT (Earnings Before Tax) | $3 | -$9 | -$56 | -$135 | -$176 | -$118 |
| Income Tax Expense | -$8 | -$11 | $3 | $2 | $0 | $0 |
| Net Income | ||||||
| Net Income | $10 | $2 | -$59 | -$137 | -$176 | -$118 |
| Per Share Data | ||||||
| Revenue Per Share | $8.13 | $7.82 | $7.29 | $6.53 | $5.36 | $4.27 |
| EPS (Basic) | $0.18 | $0.04 | -$1.02 | -$2.51 | -$3.36 | -$2.37 |
| EPS (Diluted) | $0.18 | $0.04 | -$1.02 | -$2.51 | -$3.36 | -$2.37 |
| Weighted Avg Shares (Basic) | 61.9M | 59.7M | 57.6M | 54.6M | 52.4M | 49.9M |
| Weighted Avg Shares (Diluted) | 62.5M | 61.5M | 57.6M | 54.6M | 52.4M | 49.9M |
| Shares Outstanding | 62.5M | 61.5M | 57.6M | 54.6M | 52.4M | 49.9M |
Phreesia (PHR) financials: revenue, profit and margins
Phreesia (PHR) generated about $508 million in revenue and $10 million in net income (a 2.1% net margin) over the trailing twelve months, growing at roughly 26.4% a year. Figures are from SEC filings; this is analysis, not investment advice.
Frequently asked
What is Phreesia's (PHR) revenue?+
Phreesia generated about $508 million in revenue over the trailing twelve months. Revenue has grown at roughly 26.4% a year over the past five years. Revenue is the top line, before any costs; what matters for value is how much of it survives to free cash flow. The full income statement, balance sheet and cash-flow statement are on this tab.
Is Phreesia profitable?+
Yes, Phreesia reported about $10 million in net income over the trailing twelve months, a net profit margin of roughly 2.1%. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.
What are Phreesia's profit margins?+
Phreesia runs a gross margin of about 41.0%, an operating margin of about 2.5%, a net margin of about 2.1%. Margins show how much of each sales dollar a company keeps at each stage. Stable or rising margins usually signal pricing power and cost discipline; falling margins are worth investigating. See the multi-year trend on this tab.
How fast is Phreesia growing?+
Phreesia's revenue has compounded at roughly 26.4% a year over the past five years. Growth only creates value when it is profitable and cash-generative, so read this rate alongside PHR's margins and free cash flow. This is analysis from SEC filings, not investment advice.
SourceFinancial statements computed from the 10-Q filed 27 Aug 2026, covering the period ending 31 Jul 2026, as reported to the SEC. Data last refreshed 12 Oct 2026. How this is calculated.
Fiscal year ends Jan.
Peers
Services-Business Services, NEC · Pick stocks to compare with PHR
Held by ETFs
PHR is in 27 US ETFs. The largest of them, with PHR's weight in each:
Vanguard Health Care ETFVHT0.01%of the fund
iShares Russell 2000 Growth ETFIWO0.04%of the fund
Fidelity Enhanced Small Cap ETFFESM0.07%of the fund
Pacer US Small Cap Cash Cows ETFCALF0.07%of the fund
Invesco RAFI US 1500 Small-Mid ETFPRFZ0.03%of the fund
Spot a number that looks wrong? Check it in PHR's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing PHR
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.